These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23379513)

  • 21. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
    Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
    J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.
    Beedle AM; Turner AJ; Saito Y; Lueck JD; Foltz SJ; Fortunato MJ; Nienaber PM; Campbell KP
    J Clin Invest; 2012 Sep; 122(9):3330-42. PubMed ID: 22922256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development.
    Henion TR; Qu Q; Smith FI
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):177-81. PubMed ID: 12670716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
    Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
    Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
    Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
    Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fukutin and alpha-dystroglycanopathies.
    Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
    Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
    Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
    Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent Advances in α-dystroglycanopathy].
    Kuga A; Kanagawa M; Toda T
    Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice.
    Whitmore C; Fernandez-Fuente M; Booler H; Parr C; Kavishwar M; Ashraf A; Lacey E; Kim J; Terry R; Ackroyd MR; Wells KE; Muntoni F; Wells DJ; Brown SC
    Hum Mol Genet; 2014 Apr; 23(7):1842-55. PubMed ID: 24234655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice.
    Saito F; Kanagawa M; Ikeda M; Hagiwara H; Masaki T; Ohkuma H; Katanosaka Y; Shimizu T; Sonoo M; Toda T; Matsumura K
    Hum Mol Genet; 2014 Sep; 23(17):4543-58. PubMed ID: 24722207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Journey into muscular dystrophies caused by abnormal glycosylation.
    Muntoni F
    Acta Myol; 2004 Sep; 23(2):79-84. PubMed ID: 15605948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophy.
    Kanagawa M; Lu Z; Ito C; Matsuda C; Miyake K; Toda T
    PLoS One; 2014; 9(9):e106721. PubMed ID: 25198651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fukutin-Related Protein: From Pathology to Treatments.
    Ortiz-Cordero C; Azzag K; Perlingeiro RCR
    Trends Cell Biol; 2021 Mar; 31(3):197-210. PubMed ID: 33272829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage.
    Sudo A; Kanagawa M; Kondo M; Ito C; Kobayashi K; Endo M; Minami Y; Aiba A; Toda T
    Hum Mol Genet; 2018 Apr; 27(7):1174-1185. PubMed ID: 29360985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
    Zhang Z; Zhang P; Hu H
    PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.
    Clement E; Mercuri E; Godfrey C; Smith J; Robb S; Kinali M; Straub V; Bushby K; Manzur A; Talim B; Cowan F; Quinlivan R; Klein A; Longman C; McWilliam R; Topaloglu H; Mein R; Abbs S; North K; Barkovich AJ; Rutherford M; Muntoni F
    Ann Neurol; 2008 Nov; 64(5):573-82. PubMed ID: 19067344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.
    Jimenez-Mallebrera C; Torelli S; Feng L; Kim J; Godfrey C; Clement E; Mein R; Abbs S; Brown SC; Campbell KP; Kröger S; Talim B; Topaloglu H; Quinlivan R; Roper H; Childs AM; Kinali M; Sewry CA; Muntoni F
    Brain Pathol; 2009 Oct; 19(4):596-611. PubMed ID: 18691338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity.
    Awano H; Blaeser A; Wu B; Lu P; Keramaris-Vrantsis E; Lu Q
    Neuromuscul Disord; 2015 Jun; 25(6):474-84. PubMed ID: 25937147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.